Health is considered to be a key indicator of well-being and Luxembourg has the ambition to provide excellent healthcare to its population and to be a frontrunner in the implementation of the latest health technologies. Especially in the field of personalised data-driven digital medicine, Luxembourg wants to be among the leading countries in the world.
Luxembourg therefore needs biomedical research that will ultimately be beneficial to the patient and contribute to the consolidation of an innovative, sustainable and efficient health system. Following this logic, translational medicine will play an important role in the medical research carried out in Luxembourg.
Luxembourg will continue to promote the important contributions to personalised medicine from research, carried out notably under the European programmes Horizon 2020 and Horizon Europe, in order to speed up the development of more effective preventive and diagnostic tools as well as better and safer medicines for patients.
The perspective on health will nevertheless not be limited to a purely biological or medical perspective, but will include socio-economic and behavioural aspects considered in a longitudinal perspective throughout the lifespan, which should permit an emphasis on disease prevention and behavioural changes.